Related Experiment Video

Updated: Oct 6, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.4K

Clinical characteristics of children hospitalized for COVID-19

Rosa María Luz Romero1, Marta Illán Ramos1, Arantxa Berzosa Sánchez1

  • 1Servicio de Pediatría, Hospital Clínico San Carlos, Madrid, España.

Medicina Clinica
|January 18, 2022
PubMed

Insights

Most pediatric COVID-19 cases are mild respiratory infections. Severe cases include SARS-CoV-2-associated multi-system inflammatory syndrome (MIS-C), requiring intensive care but often having a good prognosis with early diagnosis.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Epidemiology

Background:

  • Most SARS-CoV-2 infections in children present as asymptomatic or mild respiratory illness.
  • A small subset of pediatric cases develop severe outcomes, notably SARS-CoV-2-associated multi-system inflammatory syndrome (MIS-C).
  • Understanding the clinical and epidemiological features of pediatric COVID-19 is crucial for effective management.

Observation:

  • A retrospective study analyzed 30 pediatric patients hospitalized with confirmed SARS-CoV-2 infection between the pandemic's start and May 2021.
  • Patients were categorized into respiratory infection, MIS-C, or compatible symptoms groups.
  • Data collected included epidemiological and clinical characteristics, laboratory results, treatments, and patient outcomes.

Findings:

  • Children with pneumonia often presented with older age, comorbidities, and lymphopenia.
  • MIS-C cases were characterized by greater severity, significant laboratory abnormalities, and increased Pediatric Intensive Care Unit (PICU) admissions.
  • A majority of MIS-C cases resulted from secondary transmission within family contacts.

Implications:

  • Mild to moderate respiratory symptoms are the most common clinical presentation of COVID-19 in children, typically with favorable outcomes.
  • MIS-C represents a severe manifestation of SARS-CoV-2 infection in pediatric patients, emphasizing the importance of early diagnosis and PICU care for improved prognosis.
  • This study highlights the distinct clinical trajectories of SARS-CoV-2 infection in children, differentiating between common respiratory illness and severe inflammatory syndromes.
Abstract

Keywords:
COVID-19HospitalizaciónHospitalizationPediatricPediatría

More Related Videos

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.0K
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.6K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
514
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
670
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
908
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
384
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
263
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
491